ClinicalTrials.gg
Drug

Osilodrostat clinical trials

Also written LCI699 and isturisa.

studies test it
18
open now
7
in phase 3
2
first study started
2008

How each study uses Osilodrostat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Osilodrostat studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
6 Mar 2020 · ISTURISA · NDA 212801 (FDA, Drugs@FDA)
European Union
9 Jan 2020 · Isturisa · EMEA/H/C/004821 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

osilodrostat
10
Osilodrostat (Isturisa)
2
Osilodrostat 1 MG
2

Brand

isturisa
2

Development codes

LCI699
12

Studies by the year they started

18 studies that test it; most in 2026 (5)

Studies that test Osilodrostat, by start year
YearStudies
20083
20091
20111
20141
20153
20161
20181
20211
20251
20265

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
10
Phase 3
2
Phase 4
4

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 13 · Other 5

Novartis Pharmaceuticals (7) · RECORDATI GROUP (3) · Novartis (3) · University of Basrah (1) · Beckey Trinh (1) · Johns Hopkins University (1) · Mayo Clinic (1) · Laikο General Hospital, Athens (1)

Often tested with

Tested in the same studies.

Cabergoline (1) · Metyrapone (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3

Studies that test Osilodrostat.

Studies

Open first, then newest update. How each study uses Osilodrostat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 18

Codes

What other systems call Osilodrostat · ClinicalTrials.gg INT005732

  • MeSH (NLM) C553306OsilodrostatConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 5YL4IQ1078OSILODROSTATConfirmed FDA, NLM, Wikidata
  • RxNorm 2286252Confirmed FDA, Wikidata
  • Wikidata Q27088216osilodrostatConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C131535OsilodrostatOne source FDA
  • DrugBank DB11837One source Wikidata

Also registered as osilodrostat phosphate (UNII Y6581YAW9V · RxNorm 2286253).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.